Cannabix Technologies Inc., a company operating within the Information Technology sector, specifically in the Electronic Equipment, Instruments & Components industry, has been making strides in the development of marijuana breathalyzers. These devices are designed for use by law enforcement and workplaces across North America, addressing the growing need for reliable tools to measure marijuana impairment.
As of May 27, 2026, Cannabix Technologies Inc. is listed on the Canadian National Stock Exchange, with its shares trading at a close price of CAD 0.65. The company’s stock has experienced fluctuations over the past year, reaching a 52-week high of CAD 0.95 on March 18, 2026, and a low of CAD 0.455 on September 15, 2025. The market capitalization of Cannabix Technologies Inc. stands at CAD 89,680,000, reflecting its current valuation in the market.
Despite its innovative product offerings, the company’s financial metrics indicate challenges. The price-to-earnings ratio is currently at -12.542, suggesting that the company is not yet profitable. This negative ratio is indicative of the company’s current financial performance, where earnings are either negative or not substantial enough to provide a positive valuation metric.
Cannabix Technologies Inc. continues to focus on its core mission of enhancing safety and compliance in environments where marijuana use is prevalent. By providing law enforcement and employers with effective tools to assess impairment, the company aims to contribute to public safety and workplace productivity. As the legal landscape around marijuana use evolves, Cannabix Technologies Inc. is positioned to play a crucial role in the development and deployment of technology solutions that address these emerging needs.
